Christopher Ronald Donnelly, aged 68, died of Sudden Unexpected Death in Epilepsy (SUDEP). He had a 5-year history of seizures managed with antiepileptic medications, including a recent switch from valproate to levetiracetam (Keppra) in October 2019 due to inadequate seizure control. His seizures had improved on the new regimen with only 2 seizures in the 3 months prior to death. He also had vascular dementia, COPD, and depression. A family member raised concerns about prescribing Keppra given his mental health issues and dementia, but the coronial medical consultant confirmed the epilepsy management was of good standard, with Dr H. appropriately aware of potential psychiatric side-effects. The coroner found no preventable factors and no recommendations for change were warranted.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.
Specialties
neurologygeneral practicepsychiatrygeriatric medicine
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.